On this page of StockholderLetter.com we present the latest annual shareholder letter from DocGo Inc. — ticker symbol DCGO. Reading current and past DCGO letters to shareholders can bring important insights into the investment thesis.
ANNUAL REPORT 2024 LEADING THE PROACTIVE HEALTHCARE REVOLUTION

BOARD OF DIRECTORS Stephen K. Klasko, MD, MBA 1, 3 Chair of the Board of DocGo Inc. Advisor and board member in the healthcare industry. Lee Bienstock Director Chief Executive Officer of DocGo Inc. Ely D. Tendler Director General Counsel and Secretary of DocGo Inc. Vina Leite 2, 3 Director Chief People Officer of GoodRx, Inc., a publicly traded company that offers digital resources for healthcare. Michael Burdiek 1, 2 Director Former Chief Executive Officer and Director of Motion Acquisition Corp. and current board member and advisor to public and private technology growth companies. Ira Smedra 1, 2, 3 Director Founder and President of the ARBA Group, a real estate investment company with a healthcare portfolio including more than 150 skilled nursing facilities located in eight states and two acute care hospitals. James M. Travers Director Former Chairman of Motion Acquisition Corp. and former executive at technology and software companies. 1 Member of the Audit and Compliance Committee 2 Member of the Compensation Committee 3 Member of the Nominating and Corporate Governance Committee EXECUTIVE OFFICERS Lee Bienstock Chief Executive Officer Ely Tendler General Counsel and Secretary Norman Rosenberg Chief Financial Officer and Treasurer Stephen Sugrue Chief Compliance Officer The letters that follow include forward-looking statements within the meaning of SEC rules. All statements other than statements of historical fact, including, without limitation, statements regarding the Company s business strategy and plans, and objectives and goals of management for future operations are forward-looking statements. For more information about the risks associated with forward-looking statements, please see the Risk Factors and Management s Discussion and Analysis of Financial Condition and Results of Operations sections of this Annual Report on Form 10-K.
Dear Fellow Shareholders: This is my first letter to you as the new Board Chair of DocGo and I am both honored and excited to serve you in this role. As a former dean of medicine, CEO of academic health systems, president of a university, and as special advisor to a venture capital firm focused on digital transformation, I firmly believe DocGo is an essential part of the critical shift taking place in American healthcare today the revolution in proactive care. To start at the beginning: People really just want to thrive and be happy, without healthcare getting in the way. When care is needed, they would prefer to receive it in the comfort of their home, instead of spending hours waiting to be treated at an emergency room. Hospitals are a vital component of our healthcare system, but too often, they are flooded with patients seeking care for low-acuity issues. This places an undue strain on our overall healthcare system, overburdening thinly stretched resources and increasing the cost of treatment. In an ideal world, hospitals would focus on treating high-acuity patients, while lower-acuity needs would be treated at home. Additionally, patients would receive care based on anticipated need, so that health issues are addressed before they escalate to the level of crisis. DocGo is working to make the vision of healthcare at any address a reality, by combining technology, a team of thousands of medical clinicians, and a vertically integrated mobile health offering to facilitate care for millions of patients and deliver meaningful outcomes. They continue to create programs and work with their partners to bring care to patients where they are, when they need it. And when hospital visits are necessary, they deploy their fleet of ambulances to transport patients with compassion and care. It is a privilege to help DocGo lead this transformation, as we continue to deliver value for our patients, our partners, our shareholders, and our dedicated team of clinicians. This truly is a mission-driven company that embodies its Just Go spirit. I am proud to help lead this dynamic team. I remain inspired by the positive changes they are galvanizing in healthcare today, and their vision for an even healthier future. Thank you, Stephen K. Klasko Chair of the Board DocGo

 • shareholder letter icon 4/24/2025 Letter Continued (Full PDF)
 • stockholder letter icon 4/26/2023 DCGO Stockholder Letter
 • stockholder letter icon 4/25/2024 DCGO Stockholder Letter
 • stockholder letter icon More "Diagnostics" Category Stockholder Letters
 • Benford's Law Stocks icon DCGO Benford's Law Stock Score = 55


DCGO Shareholder/Stockholder Letter Transcript:

ANNUAL
REPORT
2024
LEADING THE PROACTIVE HEALTHCARE REVOLUTION


BOARD OF DIRECTORS
Stephen K. Klasko, MD, MBA 1, 3
Chair of the Board of DocGo Inc.
Advisor and board member in the
healthcare industry.
Lee Bienstock
Director
Chief Executive Officer of DocGo Inc.
Ely D. Tendler
Director
General Counsel and Secretary of DocGo Inc.
Vina Leite 2, 3
Director
Chief People Officer of GoodRx, Inc., a publicly
traded company that offers digital resources
for healthcare.
Michael Burdiek 1, 2
Director
Former Chief Executive Officer and Director
of Motion Acquisition Corp. and current
board member and advisor to public and private
technology growth companies.
Ira Smedra 1, 2, 3
Director
Founder and President of the ARBA Group,
a real estate investment company with a
healthcare portfolio including more than 150
skilled nursing facilities located in eight states
and two acute care hospitals.
James M. Travers
Director
Former Chairman of Motion Acquisition Corp.
and former executive at technology and
software companies.
1 Member of the Audit and Compliance Committee
2 Member of the Compensation Committee
3 Member of the Nominating and Corporate Governance Committee
EXECUTIVE OFFICERS
Lee Bienstock
Chief Executive Officer
Ely Tendler
General Counsel and Secretary
Norman Rosenberg
Chief Financial Officer and Treasurer
Stephen Sugrue
Chief Compliance Officer
The letters that follow include forward-looking statements within the meaning of SEC rules. All statements other than statements of historical fact,
including, without limitation, statements regarding the Company   s business strategy and plans, and objectives and goals of management for future
operations are forward-looking statements. For more information about the risks associated with forward-looking statements, please see the    Risk
Factors    and    Management   s Discussion and Analysis of Financial Condition and Results of Operations    sections of this Annual Report on Form 10-K.

Dear Fellow Shareholders:
This is my first letter to you as the new Board Chair of DocGo and I am both honored and excited to
serve you in this role. As a former dean of medicine, CEO of academic health systems, president of
a university, and as special advisor to a venture capital firm focused on digital transformation, I firmly
believe DocGo is an essential part of the critical shift taking place in American healthcare today     the
revolution in proactive care.
To start at the beginning: People really just want to thrive and be happy, without healthcare getting
in the way. When care is needed, they would prefer to receive it in the comfort of their home, instead
of spending hours waiting to be treated at an emergency room. Hospitals are a vital component of our
healthcare system, but too often, they are flooded with patients seeking care for low-acuity issues.
This places an undue strain on our overall healthcare system, overburdening thinly stretched resources
and increasing the cost of treatment. In an ideal world, hospitals would focus on treating high-acuity
patients, while lower-acuity needs would be treated at home. Additionally, patients would receive care
based on anticipated need, so that health issues are addressed before they escalate to the level of crisis.
DocGo is working to make the vision of healthcare at any address a reality, by combining technology,
a team of thousands of medical clinicians, and a vertically integrated mobile health offering to facilitate
care for millions of patients and deliver meaningful outcomes. They continue to create programs and
work with their partners to bring care to patients where they are, when they need it. And when hospital
visits are necessary, they deploy their fleet of ambulances to transport patients with compassion
and care.
It is a privilege to help DocGo lead this transformation, as we continue to deliver value for our patients,
our partners, our shareholders, and our dedicated team of clinicians.
This truly is a mission-driven company that embodies its    Just Go    spirit. I am proud to help lead this
dynamic team. I remain inspired by the positive changes they are galvanizing in healthcare today,
and their vision for an even healthier future.
Thank you,
Stephen K. Klasko
Chair of the Board
DocGo




shareholder letter icon 4/24/2025 Letter Continued (Full PDF)
 

DCGO Stockholder/Shareholder Letter (DocGo Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.